Literature DB >> 23656341

The potential and promise of mefenamic acid.

Nevio Cimolai1.   

Abstract

Clinical use of mefenamic acid has generally declined in an era where other NSAID use has flourished. While having modes of action and general toxicities similar to other NSAIDs, mefenamic acid, as a member of the fenamates, nevertheless possesses some unique in vitro effects that have the potential to distinguish this agent from others. Use of this drug remains relevant for pain syndromes and some gynecological disorders, albeit with considerable competition from other NSAIDs. New basic science has considerably improved the understanding of the biochemistry of mefenamic acid. As well as maintaining its use in traditional settings, there is a tremendous potential for expanding the application of mefenamic acid to niche roles.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23656341     DOI: 10.1586/ecp.13.15

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  7 in total

1.  Case Files of the University of California, San Francisco Medical Toxicology Fellowship: Seizures and a Persistent Anion Gap Metabolic Acidosis.

Authors:  Ann Arens; Craig Smollin
Journal:  J Med Toxicol       Date:  2016-04-14

2.  Mefenamic acid decreases inflammation but not joint lesions in experimental osteoarthritis.

Authors:  Grazielle C Aguiar; Celso M Queiroz-Junior; Giovana L Sitta; Flávio A Amaral; Mauro M Teixeira; Marcelo V Caliari; Anderson J Ferreira
Journal:  Int J Exp Pathol       Date:  2016-12       Impact factor: 1.925

3.  Microparticulated Mefenamic Acid with High Dispersion Stability for Pediatric Dosage Form.

Authors:  Moe Yamazaki; Emi Shimamura; Takehisa Hanawa; Yayoi Kawano
Journal:  Children (Basel)       Date:  2022-06-09

4.  Fragmentation Method for Computing Quantum Mechanics and Molecular Mechanics Gradients for Force Matching: Validation with Hydration Free Energy Predictions Using Adaptive Force Matching.

Authors:  Dong Zheng; Ying Yuan; Feng Wang
Journal:  J Phys Chem A       Date:  2022-04-14       Impact factor: 2.944

5.  Dissolution Behavior of Flufenamic Acid in Heated Mixtures with Nanocellulose.

Authors:  Athanasios Mantas; Albert Mihranyan
Journal:  Molecules       Date:  2020-03-11       Impact factor: 4.411

Review 6.  Fenamates as Potential Therapeutics for Neurodegenerative Disorders.

Authors:  Jaunetta Hill; Nasser H Zawia
Journal:  Cells       Date:  2021-03-22       Impact factor: 6.600

7.  Solubility enhancement of mefenamic acid by inclusion complex with β-cyclodextrin: in silico modelling, formulation, characterisation, and in vitro studies.

Authors:  Dounia Sid; Milad Baitiche; Zineb Elbahri; Ferhat Djerboua; Mokhtar Boutahala; Zouhair Bouaziz; Marc Le Borgne
Journal:  J Enzyme Inhib Med Chem       Date:  2021-12       Impact factor: 5.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.